GDTC Stock Analysis: Buy, Sell, or Hold?
GDTC - CytoMed Therapeutics Limited Ordinary Shares
$1.15
0.01 (0.88%)
▲
5d:
+0.0%
30d:
+30.65%
90d:
+9.52%
BUY
MODERATE Confidence
Analysis Updated: Jun 15, 2026 12:00 AM ET
Earnings: Jun 30, 2026
13d
Get Alerted When GDTC Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: GDTC shows positive signals but monitor for confirmation. Moderate conviction.
💡 BUY OPPORTUNITY: GDTC shows positive signals but monitor for confirmation. Moderate conviction.
In-depth Analysis How we analyze
Valuation Analysis: GDTC is currently trading at $1.15, which is considered fair relative to its 30-day fair value range of $0.94 to $1.25.
Technical Outlook: Technically, GDTC is in a uptrend. Immediate support is located at $1.02, while resistance sits at $1.29.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $5.00 (+334.8%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, GDTC is in a uptrend. Immediate support is located at $1.02, while resistance sits at $1.29.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $5.00 (+334.8%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$0.94 -
$1.25
Company Quality Score
52/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
74.7%
All Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 334.8% below Wall St target ($5.00)
Trading Range Analysis
30-Day Trading Range
$0.94 -
$1.25
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$1.02
Resistance Level
$1.29
Current Trend
Uptrend
Technical data as of
Jun 9, 2026
Fundamental Context
Wall Street Target
$5.00
(+334.8%)
Revenue Growth (YoY)
46.9%
Share & Embed Analysis
Last updated: June 16, 2026 9:36 AM ET
Data refreshes hourly during market hours. Next update: 10:36 AM
Data refreshes hourly during market hours. Next update: 10:36 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is GDTC showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
LEGN
Legend Biotech Corp |
STRONG BUY
22 analysts |
$58 | 55 HOLD |
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$52 | 57 HOLD |
|
KYMR
Kymera Therapeutics Inc |
STRONG BUY
20 analysts |
$119 | 57 HOLD |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
19 analysts |
$93 | 53 HOLD |
|
JAZZ
Jazz Pharmaceuticals PLC |
STRONG BUY
18 analysts |
$256 | 59 HOLD |
